169 related articles for article (PubMed ID: 9568805)
1. Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency.
Thacker MJ; Hainline B; St Dennis-Feezle L; Johnson NB; Pescovitz OH
Horm Res; 1998; 49(5):216-20. PubMed ID: 9568805
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
Angulo M; Castro-Magana M; Mazur B; Canas JA; Vitollo PM; Sarrantonio M
J Pediatr Endocrinol Metab; 1996; 9(3):393-400. PubMed ID: 8887149
[TBL] [Abstract][Full Text] [Related]
3. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
4. Is there growth hormone deficiency in prader-willi Syndrome? Six arguments to support the presence of hypothalamic growth hormone deficiency in Prader-Willi syndrome.
Eiholzer U; Bachmann S; l'Allemand D
Horm Res; 2000; 53 Suppl 3():44-52. PubMed ID: 10971104
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome.
Cohen M; Harrington J; Narang I; Hamilton J
Clin Endocrinol (Oxf); 2015 Aug; 83(2):212-5. PubMed ID: 25495188
[TBL] [Abstract][Full Text] [Related]
6. Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administration.
Rigamonti AE; Grugni G; Marazzi N; Bini S; Bidlingmaier M; Sartorio A
Growth Horm IGF Res; 2015 Aug; 25(4):168-73. PubMed ID: 26059749
[TBL] [Abstract][Full Text] [Related]
7. Circulating insulin-like growth factor 1 levels are reduced in very young children with Prader-Willi syndrome independent of anthropometric parameters and nutritional status.
Koizumi M; Konishi A; Etani Y; Ida S; Kawai M
Clin Endocrinol (Oxf); 2022 Mar; 96(3):346-352. PubMed ID: 34750859
[TBL] [Abstract][Full Text] [Related]
8. The growth hormone response to hexarelin in patients with Prader-Willi syndrome.
Cappa M; Raguso G; Palmiotto T; Faedda A; Gurreri F; Neri G; Deghenghi R; Loche S
J Endocrinol Invest; 1998 Sep; 21(8):501-5. PubMed ID: 9801990
[TBL] [Abstract][Full Text] [Related]
9. What is the value of growth hormone therapy in Prader Willi syndrome?
Bridges N
Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of GH deficiency in Prader-Willi syndrome.
Grugni G; Marzullo P
Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):785-794. PubMed ID: 27974191
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
Allen DB; Carrel AL
J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome.
Grugni G; Crinò A; Pagani S; Meazza C; Buzi F; De Toni T; Gargantini L; Pilotta A; Pozzan GB; Radetti G; Ragusa L; Salvatoni A; Sartorio A; Bozzola M;
J Pediatr Endocrinol Metab; 2011; 24(7-8):477-81. PubMed ID: 21932585
[TBL] [Abstract][Full Text] [Related]
13. Prader-Willi syndrome and growth hormone deficiency.
Aycan Z; Baş VN
J Clin Res Pediatr Endocrinol; 2014; 6(2):62-7. PubMed ID: 24932597
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment.
Festen DA; Visser TJ; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2007 Sep; 67(3):449-56. PubMed ID: 17716335
[TBL] [Abstract][Full Text] [Related]
15. GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology.
Corrias A; Bellone J; Beccaria L; Bosio L; Trifirò G; Livieri C; Ragusa L; Salvatoni A; Andreo M; Ciampalini P; Tonini G; Crinò A
J Endocrinol Invest; 2000 Feb; 23(2):84-9. PubMed ID: 10800760
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic growth hormone-releasing hormone (GHRH) cell number is increased in human illness, but is not reduced in Prader-Willi syndrome or obesity.
Goldstone AP; Unmehopa UA; Swaab DF
Clin Endocrinol (Oxf); 2003 Jun; 58(6):743-55. PubMed ID: 12780752
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably.
Lindgren AC; Hagenäs L; Müller J; Blichfeldt S; Rosenborg M; Brismar T; Ritzén EM
Acta Paediatr; 1998 Jan; 87(1):28-31. PubMed ID: 9510443
[TBL] [Abstract][Full Text] [Related]
18. The impact of growth hormone/insulin-like growth factor-I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome.
Marzullo P; Marcassa C; Campini R; Eleuteri E; Minocci A; Priano L; Temporelli P; Sartorio A; Vettor R; Liuzzi A; Grugni G
J Clin Endocrinol Metab; 2005 Oct; 90(10):5639-46. PubMed ID: 16030173
[TBL] [Abstract][Full Text] [Related]
19. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.
Burman P; Ritzén EM; Lindgren AC
Endocr Rev; 2001 Dec; 22(6):787-99. PubMed ID: 11739333
[TBL] [Abstract][Full Text] [Related]
20. Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children.
Sohn YB; Kwak MJ; Kim SJ; Park SW; Kim CH; Kim MY; Kwon EK; Paik KH; Jin DK
J Clin Endocrinol Metab; 2010 Mar; 95(3):1371-7. PubMed ID: 20061428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
